Paper39335355
Alzheimer's Disease-Related Cerebrospinal Fluid Biomarkers in Progressive Supranuclear Palsy.
Ishiguro T and 1 other. Brain Sci, 2024. Cited by 7 papers, by iCite.
Cite this record
ConductScience Library. Alzheimer's Disease-Related Cerebrospinal Fluid Biomarkers in Progressive Supranuclear Palsy. Papers, record 39335355. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39335355
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Alzheimer's Disease-Related Cerebrospinal Fluid Biomarkers in Progressive Supranuclear Palsy.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| JPMH24GB0101 | MHLW Research on Dementia Program | PubMed |
Source PubMed
References91
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 36832271 | CSF Aβ42 and Aβ42/Aβ40 Ratio in Alzheimer's Disease and Frontotemporal Dementias. | Diagnostics (Basel) | 2023 | https://conductscience.org/library/papers/36832271 | PubMed |
| 2 | 22526019 | CSF biomarkers cutoffs: the importance of coincident neuropathological diseases. | Acta Neuropathol | 2012 | https://conductscience.org/library/papers/22526019 | PubMed |
| 3 | 36153607 | Higher levels of myelin are associated with higher resistance against tau pathology in Alzheimer's disease. | Alzheimers Res Ther | 2022 | https://conductscience.org/library/papers/36153607 | PubMed |
| 4 | 33581485 | Association of PSP phenotypes with survival: A brain-bank study. | Parkinsonism Relat Disord | 2021 | https://conductscience.org/library/papers/33581485 | PubMed |
| 5 | 25332445 | Alzheimer CSF biomarkers may be misleading in normal-pressure hydrocephalus. | Neurology | 2014 | https://conductscience.org/library/papers/25332445 | PubMed |
| 6 | 31167811 | CSF biomarkers distinguish idiopathic normal pressure hydrocephalus from its mimics. | J Neurol Neurosurg Psychiatry | 2019 | https://conductscience.org/library/papers/31167811 | PubMed |
| 7 | 34385707 | Safety and efficacy of anti-tau monoclonal antibody gosuranemab in progressive supranuclear palsy: a phase 2, randomized, placebo-controlled trial. | Nat Med | 2021 | https://conductscience.org/library/papers/34385707 | PubMed |
| 8 | 28467028 | Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria. | Mov Disord | 2017 | https://conductscience.org/library/papers/28467028 | PubMed |
| 9 | 29653606 | NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease. | Alzheimers Dement | 2018 | https://conductscience.org/library/papers/29653606 | PubMed |
| 10 | 8710059 | Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. | Neurology | 1996 | https://conductscience.org/library/papers/8710059 | PubMed |
| 11 | 34961894 | CSF p-tau increase in response to Aβ-type and Danish-type cerebral amyloidosis and in the absence of neurofibrillary tangles. | Acta Neuropathol | 2022 | https://conductscience.org/library/papers/34961894 | PubMed |
| 12 | 33165511 | Assessment of 18F-PI-2620 as a Biomarker in Progressive Supranuclear Palsy. | JAMA Neurol | 2020 | https://conductscience.org/library/papers/33165511 | PubMed |
| 13 | 27068280 | CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis. | Lancet Neurol | 2016 | https://conductscience.org/library/papers/27068280 | PubMed |
| 14 | 20836136 | Cerebrospinal fluid tau and phosphorylated tau protein are elevated in corticobasal syndrome. | Mov Disord | 2011 | https://conductscience.org/library/papers/20836136 | PubMed |
| 15 | 28678775 | Cryo-EM structures of tau filaments from Alzheimer's disease. | Nature | 2017 | https://conductscience.org/library/papers/28678775 | PubMed |
| 16 | 38678852 | Combined blood Neurofilament light chain and third ventricle width to differentiate Progressive Supranuclear Palsy from Parkinson's Disease: A machine learning study. | Parkinsonism Relat Disord | 2024 | https://conductscience.org/library/papers/38678852 | PubMed |
| 17 | 35643092 | Tau biomarkers in Alzheimer's disease: towards implementation in clinical practice and trials. | Lancet Neurol | 2022 | https://conductscience.org/library/papers/35643092 | PubMed |
| 18 | 36508198 | Association of Phosphorylated Tau Biomarkers With Amyloid Positron Emission Tomography vs Tau Positron Emission Tomography. | JAMA Neurol | 2023 | https://conductscience.org/library/papers/36508198 | PubMed |
| 19 | 32125724 | Copathology in Progressive Supranuclear Palsy: Does It Matter? | Mov Disord | 2020 | https://conductscience.org/library/papers/32125724 | PubMed |
| 20 | 14107684 | PROGRESSIVE SUPRANUCLEAR PALSY. A HETEROGENEOUS DEGENERATION INVOLVING THE BRAIN STEM, BASAL GANGLIA AND CEREBELLUM WITH VERTICAL GAZE AND PSEUDOBULBAR PALSY, NUCHAL DYSTONIA AND DEMENTIA. | Arch Neurol | 1964 | https://conductscience.org/library/papers/14107684 | PubMed |
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42577438 | From clinical phenotypes to molecular precision: multimodal biomarkers for progressive supranuclear palsy. | Front Neurosci | 2026 | https://conductscience.org/library/papers/42577438 | PubMed |
| 41882788 | Tau conformation, distribution and PET imaging correlations in progressive supranuclear palsy. | Transl Neurodegener | 2026 | https://conductscience.org/library/papers/41882788 | PubMed |
| 41696714 | The Nodding syndrome cerebrospinal fluid proteome: a lens into neurodevelopmental failure consistent with environmentally triggered MECP2 dysregulation? | Front Mol Neurosci | 2026 | https://conductscience.org/library/papers/41696714 | PubMed |
| 41170969 | The underlying causes of eye movement disorders and ataxia. | Neurodegener Dis Manag | 2026 | https://conductscience.org/library/papers/41170969 | PubMed |
| 40415873 | Clinical utility of CSF Aβ38 in Japanese research and clinical cohorts. | Alzheimers Dement (Amst) | 2025 | https://conductscience.org/library/papers/40415873 | PubMed |
| 40282991 | Differentiating Progressive Supranuclear Palsy and Corticobasal Syndrome: Insights from Cerebrospinal Fluid Biomarkers-A Narrative Review. | Medicina (Kaunas) | 2025 | https://conductscience.org/library/papers/40282991 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| APP | 351 | PubTator's text mining | https://conductscience.org/library/genes/351 | NCBI Gene |
| MAPT | 4137 | PubTator's text mining | https://conductscience.org/library/genes/4137 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39335355
GET https://conductscience.org/api/papers/v1/39335355/references?page=2